Quintessence Int. 2024 Jun 28;55(6):494-502. doi: 10.3290/j.qi.b5316965.
The aim of this report was to review oral follicular lymphoid hyperplasia, with emphasis on palatal lesions.
A comprehensive search was performed on PubMed for case reports and case series of palatal follicular lymphoid hyperplasia published in the English language literature. Relevant data from collated articles was sought, including patient demographics, clinical manifestations, imaging modalities and findings, comorbidities, etiopathogenesis, lesional management, and lesional outcome. A new palatal case has also been provided to illustrate several features of this lesion.
In total, 32 cases were assembled to establish clinicopathologic correlations, representing the largest aggregation of published cases. Most of the affected patients were at least 60 years old and with a decisive female predilection. The majority of lesions were ≤ 3 cm, appearing as normal color, purple-red or red, and varied from soft to firm. Notably, 32% of palatal follicular lymphoid hyperplasias were associated with denture wear, and lesional recurrence was recorded in 16% of cases. To date, none of the reported cases of palatal follicular lymphoid hyperplasia has undergone malignant transformation.
Palatal follicular lymphoid hyperplasias often arise as a reactive process. Critical histopathologic and histochemical assessments are necessary to establish benignity. Postoperatively, clinicians should follow patients for at least 5 years for recurrence and remain vigilant for neoplastic change as several published accounts of non-oral follicular lymphoid hyperplasias have undergone malignant transformation, usually to lymphoma.
本报告旨在回顾口腔滤泡性淋巴组织增生,重点关注腭部病变。
在 PubMed 上对发表的英文文献中有关腭部滤泡性淋巴组织增生的病例报告和病例系列进行了全面检索。从汇集的文章中寻找相关数据,包括患者人口统计学、临床表现、影像学检查和发现、合并症、病因发病机制、病变处理和病变结果。还提供了一个新的腭部病例,以说明该病变的几个特征。
共收集了 32 例病例以建立临床病理相关性,这是已发表病例中最大的集合。大多数受影响的患者年龄至少 60 岁,女性占主导地位。大多数病变≤3cm,呈正常颜色、紫红色或红色,质地从柔软到坚硬不等。值得注意的是,32%的腭部滤泡性淋巴组织增生与义齿佩戴有关,16%的病例记录了病变复发。迄今为止,报告的腭部滤泡性淋巴组织增生病例均未发生恶性转化。
腭部滤泡性淋巴组织增生常为反应性病变。为了确定良性,需要进行关键的组织病理学和组织化学评估。术后,临床医生应至少随访患者 5 年以观察复发情况,并警惕肿瘤变化,因为一些已发表的非口腔滤泡性淋巴组织增生病例已经发生恶性转化,通常为淋巴瘤。